Autolus Therapeutics (AUTL) Cash from Operations (QoQ) (2018 - 2025)
Autolus Therapeutics (AUTL) Cash from Operations (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.85% |
| Sep 30, 2025 | 6.71% |
| Jun 30, 2025 | 3.68% |
| Mar 31, 2025 | -99.20% |
| Dec 31, 2024 | 50.57% |
| Sep 30, 2024 | -50.23% |
| Jun 30, 2024 | -26.09% |
| Mar 31, 2024 | -63.15% |
| Dec 31, 2023 | 38.21% |
| Sep 30, 2023 | -5.35% |
| Jun 30, 2023 | 10.07% |
| Mar 31, 2023 | -191.22% |
| Dec 31, 2022 | 54.34% |
| Sep 30, 2022 | -3.56% |
| Jun 30, 2022 | 12.05% |
| Mar 31, 2022 | -282.51% |
| Dec 31, 2021 | 73.65% |
| Sep 30, 2021 | 5.09% |
| Jun 30, 2021 | 1.96% |
| Mar 31, 2021 | -34.67% |